Non classé
Call for Board Candidates – Help Shape DiCE’s Future!
We’re seeking two dedicated representatives from our Full Member Organisations to shape DiCE’s future strategy and governance. Apply by May 23 ...
DiCE Supports Patient-Led Progress at the Biosimilar Medicines Conference 2025
At BIOS25 in Amsterdam, DiCE joined leading voices to champion patient-centred biosimilar policy. CEO Zorana Maravic called for reinvestment of sav...
DiCE Advocates for Patient-Centred Innovation at CDDF Workshop
DiCE joined experts at the CDDF Workshop to explore breakthroughs in oncology, including targeted therapies and personalised vaccines. We emphasise...
DiCE at the AIDA General Assembly 2025
The AIDA General Assembly 2025 occurred from March 24 to 25 at Imperial College London. It brought together experts, researchers, and consortium me...
ECOPOP Kick-off: Innovating Early Colorectal Cancer Care
On 19–20 March 2025, Digestive Cancers Europe participated in the official kick-off meeting of ECOPOP, a five-year research project funded by Hor...
Why the European Health Data Space (EHDS) Matters for Digestive Cancer Patients
The EHDS can significantly enhance healthcare for digestive cancer patients—but only if patients remain central to its design and implementation....
Collaboration and Progress at EASL Liver Cancer Summit 2025
From the 20th until the 22nd of February, DiCE attended the EASL Liver Cancer Summit in Paris, France. We had several inspiring meetings with repre...
DiCE Helps Shape New Liver Transplant Recommendations for Liver Cancer
Liver transplantation offers new hope for patients with liver cancer. DiCE has played a key role in shaping the most recent recommendations, which ...
Managing Gastrointestinal Symptoms from Cancer Treatment: New Guidance for Health Professionals
New expert guidance helps health professionals manage gastrointestinal issues from cancer treatment, addressing acute symptoms, pain, and long-term...
PERT Shortages and the Impact on Pancreatic Cancer Patients
For many patients with pancreatic cancer, as well as those who have undergone a pancreatectomy, or live with chronic pancreatitis or cystic fibrosi...